Production of ciclopirox vaginal suppository
2016-10-16

Ciclopirox vaginal suppositories by the Tianyi Pharmaceutical R & D Department under the import of similar drugs registered standards of research and development. The main component of this drug ciclopirox is a combination of vaginal fungal infections and fungal vaginitis. It can resist or inhibit most pathogenic molds, including dermatophytes and Candida albicans as well as non-pathogenic molds such as Gram-negative Ciclopirox olamine bacilli and Gram-positive bacilli. The drug works well in the treatment of skin infections caused by local absorption.

prev:Environmental protection
next:A month to cure onychomycosis
CopyRight Zhejiang Highdee Chemistry Co. All Rights Reserved. 备案序号:浙ICP备15028860号     技术支持:云谷中国·台州网站建设